glp 1 drug liraglutide may protect against dementia GLP-1 Semaglutide Linked to Lower Dementia

Credits: istock.org

The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).

The results of the PIONEER-3 trial have now been published in the renowned journal Journal of the American Medical Association (JAMA) and are said to be trend-setting for future therapy of type 2 diabetes.

During the day, bone resorption is suppressed due to eating, while at night it i...

As fatty liver disease continues to drive downstream costs, this signal is getting serious attention

GLP-1 medications interact with certain drugs, supplements, and substances that may reduce efficacy or increase side effects